Skip to content
2000
Volume 28, Issue 2
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Background

Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors, including abdominal obesity, hyperglycemia, hypertension, and dyslipidemia. Gastric cancer (GC) is a common malignancy with significant mortality rates. The relationship between MetS and GC risk remains controversial. This systematic review and meta-analysis aimed to evaluate the correlation between MetS and GC.

Methods

Case-control studies investigating the association between MetS and GC were obtained from various databases, including China National Knowledge Infrastructure (CNKI), SinoMed, Embase, Web of Science, The Cochrane Library, and PubMed. The search was performed from the inception of each database up until September, 2023. Two researchers independently screened the literature, extracted data, and assessed the quality of the included studies. A meta-analysis of the included literature was conducted using Stata 12.0 software. The study protocol is registered in PROSPERO (CRD42023490410).

Results

A total of eight studies involving a combined sample size of forty-four thousand eight hundred and seventy participants were included in the meta-analysis. The findings revealed that the risk of developing GC was not significantly associated with body mass index, triglycerides, hypertension, high fasting glucose, or MetS. However, it was found to be positively correlated with high-density lipoprotein cholesterol ( = 1.69, 95%: 1.35-2.12).

Conclusion

This meta-analysis suggests that MetS is not significantly associated with an increased risk of GC. The risk of GC increases with the presence of individual MetS components, such as high-density lipoprotein cholesterol. Therefore, GC prevention strategies should include lifestyle modifications and targeted interventions to manage MetS and its components.

Trial Registration

CRD42023490410 (PROSPERO).

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073290567240506162553
2024-05-17
2025-11-06

  • From This Site

    /content/journals/cchts/10.2174/0113862073290567240506162553
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. LiY. RenN. ZhangB. YangC. LiA. LiX. LeiZ. FeiL. FanS. ZhangJ. Gastric cancer incidence trends in China and Japan from 1990 to 2019: Disentangling age–period–cohort patterns.Cancer202312919810610.1002/cncr.34511 36284481
     [Google Scholar]
  2. ContiC.B. AgnesiS. ScaravaglioM. MasseriaP. DinelliM.E. OldaniM. UggeriF. Early gastric cancer: Update on prevention, diagnosis and treatment.Int. J. Environ. Res. Public Health2023203214910.3390/ijerph20032149 36767516
     [Google Scholar]
  3. HuangR.J. EppleinM. HamashimaC. ChoiI.J. LeeE. DeapenD. WooY. TranT. ShahS.C. InadomiJ.M. GreenwaldD.A. HwangJ.H. An approach to the primary and secondary prevention of gastric cancer in the united states.Clin. Gastroenterol. Hepatol.2022201022182228.e210.1016/j.cgh.2021.09.039 34624563
     [Google Scholar]
  4. KratzerT.B. JemalA. MillerK.D. NashS. WigginsC. RedwoodD. SmithR. SiegelR.L. Cancer statistics for A merican I ndian and A laska N ative individuals, 2022: Including increasing disparities in early onset colorectal cancer.CA Cancer J. Clin.202373212014610.3322/caac.21757 36346402
     [Google Scholar]
  5. HuangP.L. A comprehensive definition for metabolic syndrome.Dis. Model. Mech.200925-623123710.1242/dmm.001180 19407331
     [Google Scholar]
  6. SaklayenM.G. The Global Epidemic of the Metabolic Syndrome.Curr. Hypertens. Rep.20182021210.1007/s11906‑018‑0812‑z 29480368
     [Google Scholar]
  7. AlkhulaifiF. DarkohC. Meal timing, meal frequency and metabolic syndrome.Nutrients2022149171910.3390/nu14091719 35565686
     [Google Scholar]
  8. KarraP. WinnM. PauleckS. Bulsiewicz-JacobsenA. PetersonL. ColettaA. DohertyJ. UlrichC.M. SummersS.A. GunterM. HardikarS. PlaydonM.C. Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome.Obesity 20223071323133410.1002/oby.23444 35785479
     [Google Scholar]
  9. LimS.S. KakolyN.S. TanJ.W.J. FitzgeraldG. Bahri KhomamiM. JohamA.E. CoorayS.D. MissoM.L. NormanR.J. HarrisonC.L. RanasinhaS. TeedeH.J. MoranL.J. Metabolic syndrome in polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression.Obes. Rev.201920233935210.1111/obr.12762 30339316
     [Google Scholar]
  10. HeY. LuY. ZhuQ. WangY. LindheimS.R. QiJ. LiX. DingY. ShiY. WeiD. ChenZ. SunY. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women.Am. J. Obstet. Gynecol.20192212138.e1138.e1210.1016/j.ajog.2019.03.011 30910544
     [Google Scholar]
  11. JinE.H. HanK. LeeD.H. ShinC.M. LimJ.H. ChoiY.J. YoonK. Association between metabolic syndrome and the risk of colorectal cancer diagnosed before age 50 years according to tumor location.Gastroenterology20221633637648.e210.1053/j.gastro.2022.05.032 35643169
     [Google Scholar]
  12. LotanY. Metabolic syndrome and bladder cancer.BJU Int.202112811210.1111/bju.15322 34160131
     [Google Scholar]
  13. ShiZ. TuomilehtoJ. Kronfeld-SchorN. AlbertiG.K. SternN. El-OstaA. BiluC. EinatH. ZimmetP. The circadian syndrome predicts cardiovascular disease better than metabolic syndrome in Chinese adults.J. Intern. Med.2021289685186010.1111/joim.13204 33340184
     [Google Scholar]
  14. ChasensE.R. ImesC.C. KariukiJ.K. LuysterF.S. MorrisJ.L. DiNardoM.M. GodzikC.M. JeonB. YangK. sleep and metabolic syndrome.Nurs. Clin. North Am.202156220321710.1016/j.cnur.2020.10.012 34023116
     [Google Scholar]
  15. FanW. HuangY. ZhengH. LiS. LiZ. YuanL. ChengX. HeC. SunJ. Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms.Biomed. Pharmacother.202013211091510.1016/j.biopha.2020.110915 33254433
     [Google Scholar]
  16. MorlaccoA. ZattoniF. SoligoM. LamiV. IafrateM. ZanovelloN. Dal MoroF. Metabolic syndrome and prostate cancer treatment.Panminerva Med.202264335936410.23736/S0031‑0808.21.04511‑0 34486368
     [Google Scholar]
  17. YangX. LiX. DongY. FanY. ChengY. ZhaiL. ZhangS. ZhouJ. WangJ. Effects of metabolic syndrome and its components on the prognosis of endometrial cancer.Front. Endocrinol.20211278076910.3389/fendo.2021.780769 34975754
     [Google Scholar]
  18. Pérez-MartínA.R. Castro-EguiluzD. Cetina-PérezL. Velasco-TorresY. Bahena-GonzálezA. Montes-ServínE. González-IbarraE. Espinoza-RomeroR. Gallardo-RincónD. Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention.Bosn. J. Basic Med. Sci.202222449951010.17305/bjbms.2021.6963 35276057
     [Google Scholar]
  19. EkinciO. ErenT. Kurtoglu YakiciM. GapbarovA. AydemirM.A. SaglamZ.A. AlimogluO. Relación del síndrome metabólico con el cáncer de mama posmenopáusico.Cir. Esp.202098954054610.1016/j.cireng.2020.06.009 32197778
     [Google Scholar]
  20. SongJ.L. LiL.R. YuX.Z. ZhanL. XuZ.L. LiJ.J. SunS.R. ChenC. Association between metabolic syndrome and clinicopathological features of papillary thyroid cancer.Endocrine202275386587110.1007/s12020‑021‑02940‑6 34826117
     [Google Scholar]
  21. LeeJ.E. HanK. YooJ. YeoY. ChoI.Y. ChoB. ParkJ.H. ShinD.W. ChoJ.H. ParkY.M. Association between metabolic syndrome and risk of esophageal cancer: A nationwide population-based study.Cancer Epidemiol. Biomarkers Prev.202231122228223610.1158/1055‑9965.EPI‑22‑0703 36166509
     [Google Scholar]
  22. XiaB. HeQ. PanY. GaoF. LiuA. TangY. ChongC. TeohA.Y.B. LiF. HeY. ZhangC. YuanJ. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study.Int. J. Cancer2020147123384339310.1002/ijc.33172 32580250
     [Google Scholar]
  23. LiuY. YanC. YinS. WangT. ZhuM. LiuL. JinG. Genetic risk, metabolic syndrome, and gastrointestinal cancer risk: A prospective cohort study.Cancer Med.202312159760510.1002/cam4.4923 35730595
     [Google Scholar]
  24. CioffiG. ViapianaO. TarantiniL. OrsoliniG. IdolazziL. OgnibeniF. DalbeniA. GattiD. FassioA. AdamiG. RossiniM. GiolloA. The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases.Arthritis Res. Ther.20212318910.1186/s13075‑021‑02465‑3 33741041
     [Google Scholar]
  25. MarianiM. SassanoM. BocciaS. Metabolic syndrome and gastric cancer risk: A systematic review and meta-analysis.Eur. J. Cancer Prev.202130323925010.1097/CEJ.0000000000000618 32694278
     [Google Scholar]
  26. Hidalgo-BravoA. Rivera-ParedezB. León-ReyesG. PatiñoN. Castillejos-LópezM. SalmerónJ. Velázquez-CruzR. Unravelling the contribution of the rs7041 and rs4588 polymorphisms of the GC gene and serum vdbp levels for developing metabolic syndrome in the mexican population.Int. J. Mol. Sci.202223181058110.3390/ijms231810581 36142493
     [Google Scholar]
  27. ZhaoT. ZhangD. LiuY. FengM. XuZ. HuangH. ZhangL. LiW. LiX. The association between GC Gene polymorphisms and metabolic syndrome in chinese rural population: a case–control study.Diabetes Metab. Syndr. Obes.20221516517410.2147/DMSO.S346528 35058699
     [Google Scholar]
  28. HuangD. ShinW.K. De la TorreK. LeeH.W. MinS. ShinA. LeeJ.K. KangD. Association between metabolic syndrome and gastric cancer risk: Results from the Health Examinees Study.Gastric Cancer202326448149210.1007/s10120‑023‑01382‑5 37010633
     [Google Scholar]
  29. ChenX. ZhangW. SunX. ShiM. XuL. CaiY. ChenW. MaoC. ShenX. Metabolic syndrome predicts postoperative complications after gastrectomy in gastric cancer patients: Development of an individualized usable nomogram and rating model.Cancer Med.20209197116712410.1002/cam4.3352 33470549
     [Google Scholar]
  30. LiZ. HanH. ChangY. Association between metabolic syndrome and the incidence of gastric cancer: A meta-analysis of cohort studies.Diabetol. Metab. Syndr.20191118310.1186/s13098‑019‑0478‑y 31624504
     [Google Scholar]
  31. HuD. ZhangM. ZhangH. XiaY. LinJ. ZhengX. PengF. NiuW. Prediction of metabolic syndrome for the survival of patients with digestive tract cancer: A meta-analysis.Front. Oncol.2019928110.3389/fonc.2019.00281 31058084
     [Google Scholar]
  32. DerSimonianR. LairdN. Meta-analysis in clinical trials revisited.Contemp Clin Trial.,201545Pt A13914510.1016/j.cct.2015.09.002
     [Google Scholar]
  33. LiangX.F. Li, L.J.; Liu, J.T. A case control study of the correlation between metabolic syndrome and gastric cancer.Zhongguo Zhongliu Linchuang20194619986993
     [Google Scholar]
  34. LinX.H. HuangK.H. ChuangW.H. LuoJ.C. LinC.C. TingP.H. YoungS.H. FangW.L. HouM.C. LeeF.Y. The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy.PLoS One20181311e020693010.1371/journal.pone.0206930 30395589
     [Google Scholar]
  35. LeeJ.Y. ParkN.H. SongY.S. ParkS.M. LeeH.W. KimK.H. ChoiK.H. Prevalence of the metabolic syndrome and associated factors in korean cancer survivors.Asian Pac. J. Cancer Prev.20131431773178010.7314/APJCP.2013.14.3.1773 23679272
     [Google Scholar]
  36. ShinJ.Y. ChoiY.H. SongY.M. Metabolic syndrome in korean cancer survivors and family members: A study in a health promotion center.Nutr. Cancer20156771075108210.1080/01635581.2015.1073752 26317444
     [Google Scholar]
  37. ParkW. LeeH. KimE.H. YoonJ.Y. ParkJ.C. ShinS.K. LeeS.K. LeeY.C. KimW.H. NohS.H. Metabolic syndrome is an independent risk factor for synchronous colorectal neoplasm in patients with gastric neoplasm.J. Gastroenterol. Hepatol.20122791490149710.1111/j.1440‑1746.2012.07128.x 22432868
     [Google Scholar]
  38. ParkM.J. KimD.H. LimS.H. YimJ.Y. KimY.S. ChoK.R. KimC.H. JungH.C. SongI.S. KimS.S. YoonD.H. ShinC.S. ChoS.H. OhB.H. LeeD.H. Features of gastric neoplasm detected during the screening examination.Gut Liver, 20071103303910.5009/gnl.2007.1.1.3320485656
     [Google Scholar]
  39. JinY. FuX.X. DuanX.J. DuanR.M. HaoL.Y. Correlation of metabolic syndrome with clinicopathological characteristics of patients with gastric cancer.Canc. Res. Clin.20213311853856
     [Google Scholar]
  40. HanS.J. BaikS.J. YoonY.H. KimJ.H. LeeH.S. JeonS. ParkH. Risk of metabolic syndrome and fatty liver diseases in gastric cancer survivors: A propensity score-matched analysis.Korean J. Gastroenterol.202381415416210.4166/kjg.2022.113 37096435
     [Google Scholar]
  41. HuangZ. ZhouJ. ChenL. ZhangY. Metabolic syndrome and clinical outcomes of patients with gastric cancer: A meta-analysis.Horm. Metab. Res.202355533334210.1055/a‑2038‑5830 37011889
     [Google Scholar]
  42. ChenH. ZhengX. ZongX. LiZ. LiN. HurJ. FritzC.D.L. ChapmanW.Jr NickelK.B. TippingA. ColditzG.A. GiovannucciE.L. OlsenM.A. FieldsR.C. CaoY. Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer.Gut20217061147115410.1136/gutjnl‑2020‑321661 33037055
     [Google Scholar]
  43. YangY. MauldinP.D. EbelingM. HulseyT.C. LiuB. ThomasM.B. CampE.R. EsnaolaN.F. Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients.Cancer201311981512152010.1002/cncr.27923 23280333
     [Google Scholar]
  44. KochiT. ShimizuM. OhnoT. BabaA. SumiT. KubotaM. ShirakamiY. TsurumiH. TanakaT. MoriwakiH. Preventive effects of the angiotensin-converting enzyme inhibitor, captopril, on the development of azoxymethane-induced colonic preneoplastic lesions in diabetic and hypertensive rats.Oncol. Lett.20148122322910.3892/ol.2014.2136 24959250
     [Google Scholar]
  45. LintonM.F. YanceyP.G. TaoH. DaviesS.S. HDL function and atherosclerosis: Reactive dicarbonyls as promising targets of therapy.Circ. Res.2023132111521154510.1161/CIRCRESAHA.123.321563 37228232
     [Google Scholar]
  46. PirilloA. CatapanoA.L. NorataG.D. Biological consequences of dysfunctional HDL.Curr. Med. Chem.20192691644166410.2174/0929867325666180530110543 29848265
     [Google Scholar]
  47. Escolà-GilJ.C. CedóL. Blanco-VacaF. High-density lipoprotein cholesterol targeting for novel drug discovery: where have we gone wrong?Expert Opin. Drug Discov.20149211912410.1517/17460441.2014.871257 24328789
     [Google Scholar]
  48. HuX. LiuJ. LiW. WangC. LiG. ZhouY. DongH. Elevated serum uric acid was associated with pre-inflammatory state and impacted the role of HDL-C on carotid atherosclerosis.Nutr. Metab. Cardiovasc. Dis.20223271661166910.1016/j.numecd.2022.03.026 35469728
     [Google Scholar]
  49. ZhangJ. LiH. SunR. CaoZ. HuangJ. JiangY. MoM. LuoL. GuoQ. ChenQ. ZhangY. The mediation effect of HDL-C: Non-HDL-C on the association between inflammatory score and recurrent coronary events.Heliyon2024101e2373110.1016/j.heliyon.2023.e23731 38187341
     [Google Scholar]
  50. MartinezL.O. NajibS. PerretB. CabouC. LichtensteinL. Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins.Atherosclerosis201523818910010.1016/j.atherosclerosis.2014.11.017 25437896
     [Google Scholar]
  51. WangY. LiuF. SunL. JiaY. YangP. GuoD. ShiM. WangA. ChenG.C. ZhangY. ZhuZ. Association between human blood metabolome and the risk of breast cancer.Breast Cancer Res.2023251910.1186/s13058‑023‑01609‑4 36694207
     [Google Scholar]
  52. PihG.Y. GongE.J. ChoiJ.Y. KimM.J. AhnJ.Y. ChoeJ. BaeS.E. ChangH.S. NaH.K. LeeJ.H. JungK.W. KimD.H. ChoiK.D. SongH.J. LeeG.H. JungH.Y. Associations of serum lipid level with gastric cancer risk, pathology, and prognosis.Cancer Res. Treat.202153244545610.4143/crt.2020.599 33253515
     [Google Scholar]
  53. OhM.J. HanK. KimB. LimJ.H. KimB. KimS.G. ChoS.J. Risk of gastric cancer in relation with serum cholesterol profiles: A nationwide population-based cohort study.Medicine (Baltimore)202310248e3626010.1097/MD.0000000000036260 38050195
     [Google Scholar]
  54. ZhaoQ. WangY. HuoT. LiF. ZhouL. FengY. WeiZ. Exploration of risk factors for pancreatic cancer and development of a clinical high-risk group rating scale.J. Clin. Med.202312135810.3390/jcm12010358 36615158
     [Google Scholar]
  55. LeeS.H. Contreras PantaE.W. GibbsD. WonY. MinJ. ZhangC. RolandJ.T. HongS.H. SohnY. KrystofiakE. JangB. FerriL. SangwanV. RagoussisJ. Camilleri-BroëtS. CarusoJ. Chen-TanyolacC. StrasserM. GascardP. TlstyT.D. HuangS. ChoiE. GoldenringJ.R. Apposition of fibroblasts with metaplastic gastric cells promotes dysplastic transition.Gastroenterology2023165237439010.1053/j.gastro.2023.04.038 37196797
     [Google Scholar]
  56. YangG. ZhuoJ. LinY. ZhangM. LiuL. ChenX. GaoR. Ginsenoside rb1 prevents dysfunction of endothelial cells by suppressing inflammatory response and apoptosis in the high-fat diet plus balloon catheter-injured rabbit model via the g protein-coupled estrogen receptor-mediated phosphatidylinositol 3-kinases (pi3k)/akt pathway.Med. Sci. Monit.2019257407741710.12659/MSM.912986 31609302
     [Google Scholar]
  57. AmbroselliD. MasciulliF. RomanoE. CatanzaroG. BesharatZ.M. MassariM.C. FerrettiE. MigliaccioS. IzzoL. RitieniA. GrossoM. FormichiC. DottaF. FrigerioF. BarbieraE. GiustiA.M. IngallinaC. ManninaL. new advances in metabolic syndrome, from prevention to treatment: The role of diet and food.Nutrients202315364010.3390/nu15030640 36771347
     [Google Scholar]
  58. UgurK. ErmanF. TurkogluS. AydinY. AksoyA. LaleA. KaragözZ.K. UgurI. AkkocR.F. YalnizM. Asprosin, visfatin and subfatin as new biomarkers of obesity and metabolic syndrome.Eur. Rev. Med. Pharmacol. Sci.202226621242133 35363362
     [Google Scholar]
  59. XieJ. LiY. ZhangY. VgontzasA.N. BastaM. ChenB. XuC. TangX. Sleep duration and metabolic syndrome: An updated systematic review and meta-analysis.Sleep Med. Rev.20215910145110.1016/j.smrv.2021.101451 33618187
     [Google Scholar]
/content/journals/cchts/10.2174/0113862073290567240506162553
Loading
Correlation between Metabolic Syndrome and Gastric Cancer: Results of an Evidence-Based Strategy in Oriental Populations
Comb Chem High Throughput Screen 28, 254 (2025); https://doi.org/10.2174/0113862073290567240506162553
/content/journals/cchts/10.2174/0113862073290567240506162553
/content/journals/cchts/10.2174/0113862073290567240506162553
Loading

Data & Media loading...

Supplements

PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): gastric cancer; hyperglycemia; hypertension; lipoprotein cholesterol; meta-analysis; Metabolic syndrome

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test